Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Einas H Alkhatib"'
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2024)
IntroductionType 1 pseudohypoaldosteronism (PHA) consists of resistance to aldosterone. Neonatal presentation is characterized by salt wasting, hyperkalemia, and metabolic acidosis with high risk of mortality. Type 1 PHA can be autosomal dominant (re
Externí odkaz:
https://doaj.org/article/d1f2eb1a3ea64fb7b56d1caed631752e
Autor:
Einas H. Alkhatib, Jody B. Grundman, Anna M. Adamusiak, Melena D. Bellin, Joel P. Brooks, Kevin S. Buckley, Erin M. Janssen, Maleewan Kitcharoensakkul, Kyle P. McNerney, Thea L. Pfeifer, Brooke I. Polk, Brynn E. Marks
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
ObjectiveImmediate type I, type III, and delayed type IV hypersensitivity reactions to insulin are rare, but potentially serious complications of exogenous insulin administration required for the treatment of type 1 diabetes (T1D).MethodsWe present f
Externí odkaz:
https://doaj.org/article/67260d91f03d434c969145a124ce0cf5
Publikováno v:
Hormone Research in Paediatrics.
Introduction: A 12-year-9-month-old non-Hispanic black male with a history of growth hormone deficiency (GHD), pituitary hypoplasia, pre-diabetes, obesity, hypertension, and hyperlipidemia was initiated on weekly growth hormone (lonapegsomatropin-tcg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d07e019cd3eaa4bd8cec125b1a4031a
https://doi.org/10.1159/000530522
https://doi.org/10.1159/000530522
Publikováno v:
Oxford Medical Case Reports
Salt losing 3-β-hydroxysteroid dehydrogenase deficiency (HSD3B2) is a rare form of congenital adrenal hyperplasia, seen in G; p.His232Asp). This patient was referred to pediatric endocrinology and pediatric biochemical genetics following a fourth ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::703c416b85c140dd57a8f2d8e03cf4c0
http://europepmc.org/articles/PMC8143666
http://europepmc.org/articles/PMC8143666
Autor:
Einas H Alkhatib, Nader Kasim
Publikováno v:
Journal of the Endocrine Society
Cystic fibrosis-related diabetes (CFRD) is the most common comorbidity in those with CF, affecting 20% of adolescents and 40-50% of adults with CF. If uncontrolled, it can cause worsened pulmonary outcomes, increased hospital length of stay, and incr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3691d62eba5f5ccd090a980246f224c4
http://europepmc.org/articles/PMC7208934
http://europepmc.org/articles/PMC7208934